ThermoGenesis Corp. (NASDAQ:KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said, it had received an initial order for its BioArchive® System from a new public cord blood bank that will begin operations in Canada in early 2013.

INSM, Insmed, Inc.

** INSM reported that the FDA has lifted the clinical hold previously placed on ARIKACE (liposomal amikacin for inhalation) in patients with non-tuberculous mycobacteria lung disease. INSM continues to engage in discussions with FDA regarding the clinical hold placed on ARIKACE in Cystic Fibrosis patients with Pseudomonas lung infections.